Clinically Significant Change
The number of participants fulfilling the criteria for clinically significant change on the ITT data on the SMBQ at postassessment time point was 56% (34/61) in the W-iCBT group, 47% (29/61) in the iCBT group, and 21% (13/60) in the WLC group. At the 6 months follow-up, the proportion of clinically significant changes were W-CBT, 47% (29/61), iCBT, 48% (30/61), and WLC, 37% (22/60), respectively. On the KEDS, the proportions were 26% (16/61) in the W-iCBT group, 23% (14/61) in the iCBT group, and 7% (4/60) in the WLC group; at the 6 months follow-up, they were W-CBT, 34% (21/61); iCBT, 28% (17/61); and WLC, 11% (7/60).